Efficacy and safety of growth hormone treatment in Japanese children with small-for-gestational-age short stature in accordance with Japanese guidelines

por Yokoya, Susumu, Tanaka, Toshiaki, Itabashi, Kazuo, Osada, Hisao, Hirai, Hideaki, Seino, Yoshiki
Publicado 2018

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency

por Kohno, Hitoshi, Tanaka, Toshiaki, Fujieda, Kenji, Chihara, Kazuo, Seino, Yoshiki, Irie, Minoru, Takano, Kazue
Publicado 2012

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

por Tanaka, Toshiaki, Tai, Shigeru, Morisaki, Yoji, Tachibana, Katsuhiko, Kambayashi, Yasuko, Chihara, Kazuo, Seino, Yoshiki, Fujieda, Kenji
Publicado 2009

Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan

por Tanaka, Toshiaki, Yokoya, Susumu, Seino, Yoshiki, Tada, Hiroshi, Mishina, Jun, Sato, Takahiro, Hiro, Shintaro, Ohki, Nobuhiko
Publicado 2015

Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan

por Tanaka, Toshiaki, Yokoya, Susumu, Seino, Yoshiki, Tada, Hiroshi, Mishina, Jun, Sato, Takahiro, Hiro, Shintaro, Ohki, Nobuhiko
Publicado 2015

Efficacy and Safety of Up to 8 Years of Long-term Growth Hormone Treatment in Short Children Born Small for Gestational Age in Japan: Analysis of the Subpopulation According to the...

por Tanaka, Toshiaki, Yokoya, Susumu, Fujieda, Kenji, Seino, Yoshiki, Tada, Hiroshi, Mishina, Jun, Saito, Susumu, Takata, Ami, Ohki, Nobuhiko
Publicado 2012

Effect of Growth Hormone Treatment on Quality of Life in Japanese Children with Growth Hormone Deficiency: An Analysis from a Prospective Observational Study

por Tanaka, Toshiaki, Hasegawa, Tomonobu, Ozono, Keiichi, Tanaka, Hiroyuki, Kanzaki, Susumu, Yokoya, Susumu, Chihara, Kazuo, Iwamoto, Noriyuki, Seino, Yoshiki
Publicado 2014

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial

por Namba, Noriyuki, Kubota, Takuo, Muroya, Koji, Tanaka, Hiroyuki, Kanematsu, Masanori, Kojima, Masahiro, Orihara, Shunichiro, Kanda, Hironori, Seino, Yoshiki, Ozono, Keiichi
Publicado 2022

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies

por Kubota, Takuo, Namba, Noriyuki, Tanaka, Hiroyuki, Muroya, Koji, Imanishi, Yasuo, Takeuchi, Yasuhiro, Kanematsu, Masanori, Sun, Wei, Seino, Yoshiki, Ozono, Keiichi
Publicado 2023

Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia

por Imanishi, Yasuo, Ito, Nobuaki, Rhee, Yumie, Takeuchi, Yasuhiro, Shin, Chan Soo, Takahashi, Yutaka, Onuma, Hiroki, Kojima, Masahiro, Kanematsu, Masanori, Kanda, Hironori, Seino, Yoshiki, Fukumoto, Seiji
Publicado 2020

Final adult height in long-term growth hormone-treated achondroplasia patients

por Harada, Daisuke, Namba, Noriyuki, Hanioka, Yuki, Ueyama, Kaoru, Sakamoto, Natsuko, Nakano, Yukako, Izui, Masafumi, Nagamatsu, Yuiko, Kashiwagi, Hiroko, Yamamuro, Miho, Ishiura, Yoshihito, Ogitani, Ayako, Seino, Yoshiki
Publicado 2017

Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International S...

por Yokoya, Susumu, Hasegawa, Tomonobu, Ozono, Keiichi, Tanaka, Hiroyuki, Kanzaki, Susumu, Tanaka, Toshiaki, Chihara, Kazuo, Jia, Nan, Child, Christopher J., Ihara, Katsuichiro, Funai, Jumpei, Iwamoto, Noriyuki, Seino, Yoshiki
Publicado 2017

Responses to the Letter to the Editor “Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?” (Vol. 27, No. 2, p. 107–108, 2018)...

por Yokoya, Susumu, Hasegawa, Tomonobu, Ozono, Keiichi, Tanaka, Hiroyuki, Kanzaki, Susumu, Tanaka, Toshiaki, Chihara, Kazuo, Jia, Nan, Child, Christopher J., Ihara, Katsuichiro, Funai, Jumpei, Iwamoto, Noriyuki, Seino, Yoshiki
Publicado 2018

First‐in‐Asian Phase I Study of the Anti‐Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X‐linked Hypophosphatemia

por Cheong, Hae Il, Yoo, Han‐Wook, Adachi, Masanori, Tanaka, Hiroyuki, Fujiwara, Ikuma, Hasegawa, Yukihiro, Harada, Daisuke, Sugimoto, Maiko, Okada, Yosuke, Kato, Masaki, Shimazaki, Ryutaro, Ozono, Keiichi, Seino, Yoshiki
Publicado 2018

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature

por Oyachi, Maki, Harada, Daisuke, Sakamoto, Natsuko, Ueyama, Kaoru, Kondo, Kawai, Kishimoto, Kanako, Izui, Masafumi, Nagamatsu, Yuiko, Kashiwagi, Hiroko, Yamamuro, Miho, Tamura, Makoto, Kikuchi, Shin, Akiyama, Tomoyuki, Michigami, Toshimi, Seino, Yoshiki, Namba, Noriyuki
Publicado 2018

Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan

por Tanaka, Toshiaki, Igarashi, Yutaka, Ozono, Keiichi, Ohyama, Kenji, Ogawa, Masamichi, Osada, Hisao, Onigata, Kazumichi, Kanzaki, Susumu, Kohno, Hitoshi, Seino, Yoshiki, Takahashi, Hiroaki, Tajima, Toshihiro, Tachibana, Katsuhiko, Tanaka, Hiroyuki, Nishi, Yoshikazu, Hasegawa, Tomonobu, Fujita, Keinosuke, Yorifuji, Tohru, Horikawa, Reiko, Yokoya, Susumu
Publicado 2015

Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner Syndrome

por Kohno, Hitoshi, Igarashi, Yutaka, Ozono, Keiichi, Ohyama, Kenji, Ogawa, Masamichi, Osada, Hisao, Onigata, Kazumichi, Kanzaki, Susumu, Seino, Yoshiki, Takahashi, Hiroaki, Tajima, Toshihiro, Tachibana, Katsuhiko, Tanaka, Hiroyuki, Nishi, Yoshikazu, Hasegawa, Tomonobu, Fujieda, Kenji, Fujita, Keinosuke, Horikawa, Reiko, Yokoya, Susumu, Yorifuji, Toru, Tanaka, Toshiaki
Publicado 2012